Use of Eltrombopag to Improve Thrombocytopenia and Transfusion Requirement in Anti-CD19 Car-T Cell-Treated Patients
How to cite: Mingot-Castellano, M.-E.; Reguera-Ortega, J. L.; Zafra Torres, D.; Hernani, R.; Lopez-Godino, O.; Guerreiro, M.; Herrero, B.; Lopez-Corral, L.; Luna, A.; González-Pinedo, L.; Chinea-Rodriguez, A.; Martin-lópez, A. A.; Bailen, R.; Martinez-Cebrian, N.; Balsalobre, P.; Filaferro, S.; Alonso-Saladrigues, A.; Barba, P.; Pérez-Martínez, A.; Calbacho, M.; Perez Simon, J. A.; Sanchez-Pina, J. M. Use of Eltrombopag to Improve Thrombocytopenia and Transfusion Requirement in Anti-CD19 Car-T Cell-Treated Patients. Preprints 2024, 2024072382. https://doi.org/10.20944/preprints202407.2382.v1 Mingot-Castellano, M.-E.; Reguera-Ortega, J. L.; Zafra Torres, D.; Hernani, R.; Lopez-Godino, O.; Guerreiro, M.; Herrero, B.; Lopez-Corral, L.; Luna, A.; González-Pinedo, L.; Chinea-Rodriguez, A.; Martin-lópez, A. A.; Bailen, R.; Martinez-Cebrian, N.; Balsalobre, P.; Filaferro, S.; Alonso-Saladrigues, A.; Barba, P.; Pérez-Martínez, A.; Calbacho, M.; Perez Simon, J. A.; Sanchez-Pina, J. M. Use of Eltrombopag to Improve Thrombocytopenia and Transfusion Requirement in Anti-CD19 Car-T Cell-Treated Patients. Preprints 2024, 2024072382. https://doi.org/10.20944/preprints202407.2382.v1
Abstract
Keywords
Subject
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)